Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Vaccine ◽  
2014 ◽  
Vol 32 (42) ◽  
pp. 5496-5502 ◽  
Author(s):  
Barry Buckland ◽  
Robert Boulanger ◽  
Mireli Fino ◽  
Indresh Srivastava ◽  
Kathy Holtz ◽  
...  
Keyword(s):  
Technology Transfer ◽  
Influenza Vaccine ◽  
Manufacturing Process ◽  
Scale Up ◽  
Recombinant Hemagglutinin

Stage 1B: Scale-Up and Technology Transfer

2019 ◽  
pp. 37-55
Author(s):  
Ajay Pazhayattil ◽  
Naheed Sayeed-Desta ◽  
Emilija Fredro-Kumbaradzi ◽  
Marzena Ingram ◽  
Jordan Collins
Keyword(s):  
Technology Transfer ◽  
Scale Up

scholarly journals Scale-Up of the Manufacturing Process To Produce Docetaxel-Loaded mPEG-b-p(HPMA-Bz) Block Copolymer Micelles for Pharmaceutical Applications

2019 ◽  
Vol 23 (12) ◽  
pp. 2707-2715 ◽  
Author(s):  
Jaleesa Bresseleers ◽  
Mahsa Bagheri ◽  
Gert Storm ◽  
Josbert M. Metselaar ◽  
Wim E. Hennink ◽  
...  
Keyword(s):  
Block Copolymer ◽  
Manufacturing Process ◽  
Scale Up ◽  
Pharmaceutical Applications ◽  
Block Copolymer Micelles ◽  
Copolymer Micelles

scholarly journals Exploring and Preparing for Successful Cross-continental Knowledge and Technology Transfer: A Case Study on International Open Innovation

2019 ◽  
Vol 5 (1) ◽  
pp. 60-76
Author(s):  
Alan Barrell ◽  
Joanne Hsu
Keyword(s):  
Technology Transfer ◽  
New Technology ◽  
Scale Up ◽  
Close Collaboration ◽  
Group A ◽  
Energy Innovation ◽  
Knowledge And Technology Transfer ◽  
The Uk ◽  
Rapid Transfer

Shanghai Energy Corporation—SHEnergy Group, a major Chinese enterprise in energy provision and the development of continuous improvements in energy conservation within urban development, is undertaking a major initiative in establishing the Shanghai International Energy Innovation Centre (SIEIC). Within the programme, study visits to London and Cambridge in the UK led to a decision to seek close collaboration with established and mature centres of excellence in technology transfer and the support of new company development and scale up, providing the rapid transfer of methodology and process and in addition to establishing longer term connections and relationships enabling the identification, curation, funding and eventual adoption of promising new technology from Cambridgexf and other UK and Western centres by SIEIC—in ways bringing benefits to all parties.

scholarly journals Formulation development of a plant-derived h1n1 influenza vaccine containing purified recombinant hemagglutinin antigen

2012 ◽  
Vol 8 (4) ◽  
pp. 453-464 ◽  
Author(s):  
Vidyashankara Iyer ◽  
Mangala Roshan Liyanage ◽  
Yoko Shoji ◽  
Jessica A. Chichester ◽  
R. Mark Jones ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
H1n1 Influenza ◽  
Formulation Development ◽  
Recombinant Hemagglutinin
Sign in / Sign up

Export Citation Format

Share Document